Tang, Bo <br/><br/>
Alpinetin suppresses proliferation of human hepatoma cells by the activation             of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.  [electronic resource] 

 -  Oncology reports  Apr 2012 
 - 1090-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2011.1580  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Blotting, Western<br/>Carcinoma, Hepatocellular--enzymology<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Enzyme Activation<br/>Enzyme Activators--pharmacology<br/>Flavanones--pharmacology<br/>Flow Cytometry<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--enzymology<br/>MAP Kinase Kinase 7--antagonists & inhibitors<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA Interference<br/>RNA, Messenger--metabolism<br/>Rats<br/>Resting Phase, Cell Cycle--drug effects<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Time Factors<br/>Transfection